Elsevier

Gastrointestinal Endoscopy

Volume 58, Issue 3, September 2003, Pages 390-408
Gastrointestinal Endoscopy

Review Article
Diagnosis and Management of Hereditary Non-Polyposis Colon Cancer

https://doi.org/10.1067/S0016-5107(03)00014-2Get rights and content

Section snippets

History

The first description of a family with HNPCC was published almost 100 years ago. In 1895, Aldred Warthin's seamstress predicted she would die at an early age from cancer of her colon or female organs because “most of my family members die of these cancers,” an observation that led Warthin to publish a description of this family with a hereditary predisposition to GI and gynecologic cancer (Fig. 1A).11, 12, 13 However, the true significance of the extensive history of cancer of the colon, the

Causative Genes

As mentioned above, it is now appreciated that most cases of HNPCC result from the inactivation of the DNA MMR process caused by germline gene defects in the genes that encode key components of the MMR DNA repair complexes. The DNA mismatch repair system (also known as the mutation mismatch repair system) consists of a complex of proteins that recognize and repair base pair mismatches that occur during DNA replication. At least 8 genes, including 7 that encode proteins involved in the MMR

Clinical Features of HNPCC

The central clinical features that should suggest the diagnosis of HNPCC are the familial clustering of HNPCC-associated tumors (i.e., colorectal, gastric, endometrial, small bowel, renal, and ureteral cancers) and a young age at onset of these tumors. Hereditary non-polyposis colon cancer is inherited in an autosomal dominant fashion and is 80% penetrant. Thus, the lifetime risk for colon cancer is 80% by age 70 years.34, 45 The mean age of diagnosis of colon cancer in an HNPCC individual is

Clinical Diagnosis

The clinical diagnostic criteria that define HNPCC have evolved gradually since the first formal criteria, the Amsterdam criteria, were published in 1990.77 Clinical criteria for defining HNPCC are necessary because two other CFSs, attenuated FAP and common familial colon cancer, can be difficult to distinguish from HNPCC (Table 1).78 In 1990, the International Collaborative Group, composed of 30 experts from 8 different countries, outlined the minimal set of clinical features that define HNPCC

Overview

Genetic tests, or assays that can detect mutations in the genes responsible for most cases of HNPCC, are currently available for routine clinical use, which has created new opportunities, as well as challenges, for the practicing gastroenterologist. Challenges include not only identifying individuals who should be considered for genetic testing but also providing genetic counseling, identifying the type of genetic test to perform and the laboratory that will perform the test, and correctly

Genetic Testing and Its Affects on Surveillance Recommendations

The substantially increased lifetime risk of colon, small bowel, gastric, and genitourinary tract cancer has led to the use of cancer surveillance regimens in HNPCC family members (Table 4). There is some evidence to suggest that the type of germline mutation present in a family may predict the absolute risk for cancer in the family, as well as the spectrum of tumor types to which these family members are predisposed. Vasen et al.107 found that carriers of MSH2 mutations are at higher risk of

Conclusions

The management of HNPCC family members is both challenging and gratifying. Currently, the field of clinical cancer genetics and molecular genetics is in a state of rapid evolution, and HNPCC is one of the syndromes at the forefront of our understanding of CFSs arising from germline mutations in DNA caretaker genes. As could be predicted, the translation of the molecular genetics of HNPCC into the clinical management has been outpaced by our understanding of the molecular biology of the genes

Disclosure

This work was supported by the Damon-Runyon/Lilly Clinical Investigator Award, the Vanderbilt Physician-Scientist Development Award, the VA Advanced Research Career Development Award, the Mallinckrodt Scholar Award, and KO8 CA77676 to W.M.G.

Acknowledgments

The investigators thank Dr. Kay Washington for providing the photomicrograph of the HNPCC colon cancer and for her helpful comments on the histopathology of HNPCC tumors. The investigators also wish to apologize to the investigators of many important studies that were not cited in this review because of space limitations. Our understanding of the genetics of colon cancer has progressed rapidly as a result of the many talented investigators actively engaged in research in this area, and it is

First page preview

First page preview
Click to open first page preview

References (136)

  • JR Jass et al.

    Emerging concepts in colorectal neoplasia

    Gastroenterology

    (2002)
  • HT Lynch et al.

    Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review

    Gastroenterology

    (1993)
  • D Chung et al.

    DNA mismatch repair and cancer

    Gastroenterology

    (1995)
  • SC Huang et al.

    Germline characterization of early-aged onset of hereditary non-polyposis colorectal cancer

    J Pediatr

    (2001)
  • J Church

    Hereditary colon cancers can be tiny: a cautionary case report of the results of colonoscopic surveillance

    Am J Gastroenterol

    (1998)
  • Y Akiyama et al.

    Transforming growth factor beta type II receptor gene mutations in adenomas from hereditary nonpolyposis colorectal cancer

    Gastroenterology

    (1997)
  • R Jacoby et al.

    Genetic instability associated with adenoma to carcinoma progression in hereditary nonpolyposis colon cancer

    Gastroenterology

    (1995)
  • J Alexander et al.

    Histopathological identification of colon cancer with microsatellite instability

    Am J Pathol

    (2001)
  • R Sankila et al.

    Better survival rates in patients with MLH1-associated hereditary colorectal cancer

    Gastroenterology

    (1996)
  • P Watson et al.

    The risk of endometrial cancer in hereditary nonpolyposis colorectal cancer

    Am J Med

    (1994)
  • HF Vasen et al.

    Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis [erratum Gastroenterology 1996;111:1402]

    Gastroenterology

    (1996)
  • HT Lynch et al.

    The Lynch syndrome II and urological malignancies

    J Urol

    (1990)
  • Y Cao et al.

    Challenge in the differentiation between attenuated familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer: case report with review of the literature

    Am J Gastroenterol

    (2002)
  • HF Vasen et al.

    New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC

    Gastroenterology

    (1999)
  • J Wijnen et al.

    Hereditary nonpolyposis colorectal cancer families not complying with the Amsterdam criteria show extremely low frequency of mismatch-repair-gene mutations

    Am J Hum Genet

    (1997)
  • A Jemal et al.

    Cancer statistics, 2002

    CA Cancer J Clin

    (2002)
  • PG Shields et al.

    Cancer risk and low-penetrance susceptibility genes in gene-environment interactions

    J Clin Oncol

    (2000)
  • R Doll

    Nature and nurture: possibilities for cancer control

    Carcinogenesis

    (1996)
  • FM Giardiello et al.

    AGA technical review on hereditary colorectal cancer and genetic testing

    Gastroenterology

    (2001)
  • LA Aaltonen et al.

    Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease

    N Engl J Med

    (1998)
  • R Salovaara et al.

    Population-based molecular detection of hereditary nonpolyposis colorectal cancer

    J Clin Oncol

    (2000)
  • M Ravnik-Glavac et al.

    Incidence of germline hMLH1 and hMSH2 mutations (HNPCC patients) among newly diagnosed colorectal cancers in a Slovenian population

    J Med Genet

    (2000)
  • A Warthin

    Heredity with reference to carcinoma

    Arch Intern Med

    (1913)
  • A Warthin

    The further study of a cancer family

    J Cancer Res

    (1925)
  • A Warthin

    Heredity of carcinoma in man

    Ann Intern Med

    (1931)
  • HT Lynch et al.

    Hereditary factors in cancer. Study of two large midwestern kindreds

    Arch Intern Med

    (1966)
  • HT Lynch et al.

    Cancer family “G” revisited: 1895-1970

    Cancer

    (1971)
  • CR Boland et al.

    Familial colonic cancer without antecedent polyposis

    Ann Intern Med

    (1984)
  • F Palombo et al.

    Mismatch repair and cancer

    Nature

    (1994)
  • C Bronner et al.

    Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer

    Nature

    (1994)
  • N Papadopoulos et al.

    Mutations in MutL homolog in hereditary colon cancer

    Science

    (1994)
  • N Nicolaides et al.

    Mutations of two PMS homologues in hereditary nonpolyposis colon cancer

    Nature

    (1994)
  • B Liu et al.

    hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds

    Cancer Res

    (1994)
  • P Peltomaki et al.

    Genetic mapping of a locus predisposing to human colorectal cancer

    Science

    (1993)
  • A Lindblom et al.

    Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer

    Nat Genet

    (1993)
  • G Marra et al.

    Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspective

    J Natl Cancer Inst

    (1995)
  • Y Wu et al.

    A role for MLH3 in hereditary nonpolyposis colorectal cancer

    Nat Genet

    (2001)
  • S Jagmohan-Changur et al.

    EXO1 variants occur commonly in normal population: evidence against a role in hereditary nonpolyposis colorectal cancer

    Cancer Res

    (2003)
  • HT Lynch et al.

    Genetic susceptibility to non-polyposis colorectal cancer

    J Med Genet

    (1999)
  • J Plaschke et al.

    Sequence analysis of the mismatch repair gene hMSH6 in the germline of patients with familial and sporadic colorectal cancer

    Int J Cancer

    (2000)
  • Cited by (0)

    View full text